The global needle-free Injectors market was valued at USD 124.2 million in 2021 and it is predicted to surpass around USD 276.3 million by 2030 with a CAGR of 9.29% from 2022 to 2030.
An increasing number of infectious diseases across the globe is escalating the demand for self-injection devices, and the rising need for vaccination is the major factor projected to fuel the market growth. An increase in the geriatric population base developing communicable diseases due to needle stick injuries is estimated to surge the demand for needle-free Injectors over the forecast period. Additionally, the rising focus of market players on developing safe, pain-free, and advanced injectors is expected to augment the market expansion.
Recent advancements and product approvals as well as upgradation in needle-free injectors are anticipated to contribute towards market growth. In August 2022, WHO nominated the PharmaJet Tropis needle-free Injection System for huge polio vaccination campaigns. In July 2022, NuGen Medical Devices Inc. announced that its InsuJet has been approved and accepted by Health Canada explicitly for the needle-free delivery of insulin.
Injections are one of the most common medical devices used for drug administration. Due to this, healthcare professionals are at great risk of exposure to bloodborne pathogens owing to needle stick injuries, which can occur accidentally. According to Occupational Safety and Health Administration (OSHA), around 590,000 needle stick accidents occur each year.
Asia Pacific region is estimated to exhibit the highest CAGR during the forecast period owing to increasing investments in the region by key market players, and rapid development of the healthcare industry in countries such as India, China, Japan, and others. Availability of low-cost labor for manufacturing, growing demand for self-injection devices, and the presence of favorable regulatory scenarios are major factors anticipated to create wide growth opportunities for current and upcoming market players.
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 124.2 million |
Revenue Forecast by 2030 | USD 276.3 million |
Growth rate from 2022 to 2030 | CAGR of 9.29% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Product, Technology, Type, Application, Usability, Delivery Site, End-use, Region |
Companies Covered |
PharmaJet, Crossject, Portal Instruments, NuGen Medical Devices, Inovio Pharmaceuticals, Antares Pharma, Inc, Aijex Pharma International Inc., Ferring B.V., Penjet Corporation, and Medical International Technology Inc. |
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Needle-free Injectors Market, By Product
7.1. Needle-free Injectors Market, by Product, 2022-2030
7.1.1. Fillable
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Prefilled
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Needle-free Injectors Market, By Technology
8.1. Needle-free Injectors Market, by Technology, 2022-2030
8.1.1. Spring-based needle-free Injectors
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Gas-powered needle-free Injectors
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Laser-powered needle-free Injectors
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Vibration-based needle-free Injectors
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Needle-free Injectors Market, By Type
9.1. Needle-free Injectors Market, by Type, 2022-2030
9.1.1. Powder-based needle-free Injectors
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Liquid-based needle-free Injectors
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Projectile/depot-based needle-free Injectors
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Needle-free Injectors Market, By Application
10.1. Needle-free Injectors Market, by Application, 2022-2030
10.1.1. Vaccine Delivery
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Insulin Delivery
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Pain Management
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Needle-free Injectors Market, By Usability
11.1. Needle-free Injectors Market, by Usability, 2022-2030
11.1.1. Reusable
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Disposable
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Needle-free Injectors Market, By Delivery Site
12.1. Needle-free Injectors Market, by Delivery Site, 2022-2030
12.1.1. Subcutaneous
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Intramuscular
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Intradermal
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Needle-free Injectors Market, By End-use
13.1. Needle-free Injectors Market, by End-use, 2022-2030
13.1.1. Hospitals & Clinics
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Home Care Settings
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Research Laboratories
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Needle-free Injectors Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.2. Market Revenue and Forecast, by Technology (2017-2030)
14.1.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.5. Market Revenue and Forecast, by Usability (2017-2030)
14.1.6. Market Revenue and Forecast, by End-use (2017-2030)
14.1.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Technology (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.8.5. Market Revenue and Forecast, by Usability (2017-2030)
14.1.8.6. Market Revenue and Forecast, by End-use (2017-2030)
14.1.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Technology (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Application (2017-2030)
14.1.9.5. Market Revenue and Forecast, by Usability (2017-2030)
14.1.9.6. Market Revenue and Forecast, by End-use (2017-2030)
14.1.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.2. Market Revenue and Forecast, by Technology (2017-2030)
14.2.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.5. Market Revenue and Forecast, by Usability (2017-2030)
14.2.6. Market Revenue and Forecast, by End-use (2017-2030)
14.2.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.8.5. Market Revenue and Forecast, by Usability (2017-2030)
14.2.8.6. Market Revenue and Forecast, by End-use (2017-2030)
14.2.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Technology (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.9.5. Market Revenue and Forecast, by Usability (2017-2030)
14.2.9.6. Market Revenue and Forecast, by End-use (2017-2030)
14.2.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Technology (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.10.5. Market Revenue and Forecast, by Usability (2017-2030)
14.2.10.6. Market Revenue and Forecast, by End-use (2017-2030)
14.2.10.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Technology (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Application (2017-2030)
14.2.11.5. Market Revenue and Forecast, by Usability (2017-2030)
14.2.11.6. Market Revenue and Forecast, by End-use (2017-2030)
14.2.11.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.2. Market Revenue and Forecast, by Technology (2017-2030)
14.3.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.5. Market Revenue and Forecast, by Usability (2017-2030)
14.3.6. Market Revenue and Forecast, by End-use (2017-2030)
14.3.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.8.5. Market Revenue and Forecast, by Usability (2017-2030)
14.3.8.6. Market Revenue and Forecast, by End-use (2017-2030)
14.3.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Technology (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.9.5. Market Revenue and Forecast, by Usability (2017-2030)
14.3.9.6. Market Revenue and Forecast, by End-use (2017-2030)
14.3.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Technology (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.10.5. Market Revenue and Forecast, by Usability (2017-2030)
14.3.10.6. Market Revenue and Forecast, by End-use (2017-2030)
14.3.10.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Technology (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Type (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Application (2017-2030)
14.3.11.5. Market Revenue and Forecast, by Usability (2017-2030)
14.3.11.6. Market Revenue and Forecast, by End-use (2017-2030)
14.3.11.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.2. Market Revenue and Forecast, by Technology (2017-2030)
14.4.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.5. Market Revenue and Forecast, by Usability (2017-2030)
14.4.6. Market Revenue and Forecast, by End-use (2017-2030)
14.4.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.8.5. Market Revenue and Forecast, by Usability (2017-2030)
14.4.8.6. Market Revenue and Forecast, by End-use (2017-2030)
14.4.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Technology (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.9.5. Market Revenue and Forecast, by Usability (2017-2030)
14.4.9.6. Market Revenue and Forecast, by End-use (2017-2030)
14.4.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Technology (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.10.5. Market Revenue and Forecast, by Usability (2017-2030)
14.4.10.6. Market Revenue and Forecast, by End-use (2017-2030)
14.4.10.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Technology (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Type (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Application (2017-2030)
14.4.11.5. Market Revenue and Forecast, by Usability (2017-2030)
14.4.11.6. Market Revenue and Forecast, by End-use (2017-2030)
14.4.11.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.2. Market Revenue and Forecast, by Technology (2017-2030)
14.5.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.4. Market Revenue and Forecast, by Application (2017-2030)
14.5.5. Market Revenue and Forecast, by Usability (2017-2030)
14.5.6. Market Revenue and Forecast, by End-use (2017-2030)
14.5.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Technology (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Application (2017-2030)
14.5.8.5. Market Revenue and Forecast, by Usability (2017-2030)
14.5.8.6. Market Revenue and Forecast, by End-use (2017-2030)
14.5.8.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Technology (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Usability (2017-2030)
14.5.9.6. Market Revenue and Forecast, by End-use (2017-2030)
14.5.9.7. Market Revenue and Forecast, by Delivery Site (2017-2030)
Chapter 15. Company Profiles
15.1. Crossject
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Portal Instruments
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. NuGen Medical Devices
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Inovio Pharmaceuticals
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Antares Pharma, Inc
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Aijex Pharma International Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Ferring B.V.
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Penjet Corporation
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Medical International Technology Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms